|
DIAPH3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.389730E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.392600E-01 |
| Normal-vs-Stage2 |
2.245600E-01 |
| Normal-vs-Stage3 |
1.585750E-02 |
| Normal-vs-Stage4 |
2.013200E-01 |
| Stage1-vs-Stage2 |
3.906800E-01 |
| Stage1-vs-Stage3 |
2.133500E-02 |
| Stage1-vs-Stage4 |
3.285200E-01 |
| Stage2-vs-Stage3 |
3.680800E-01 |
| Stage2-vs-Stage4 |
7.811000E-01 |
| Stage3-vs-Stage4 |
6.435400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.282300E-02 |
| Normal-vs-AfricanAmerican |
5.495500E-02 |
| Normal-vs-Asian |
1.130760E-01 |
| Caucasian-vs-AfricanAmerican |
4.540200E-01 |
| Caucasian-vs-Asian |
2.615200E-01 |
| AfricanAmerican-vs-Asian |
5.403600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.023570E-01 |
| Normal-vs-Female |
2.158100E-03 |
| Male-vs-Female |
2.340400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.905000E-01 |
| Normal-vs-Extreme_Weight |
7.684600E-01 |
| Normal-vs-Obese |
1.433840E-02 |
| Normal-vs-Extreme_Obese |
6.208800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.929000E-01 |
| Normal_Weight-vs-Obese |
2.585400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.177800E-01 |
| Extreme_Weight-vs-Obese |
2.393800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.609000E-01 |
| Obese-vs-Extreme_Obese |
4.637200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.114300E-02 |
| Normal-vs-Age(41-60Yrs) |
5.918900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.954230E-01 |
| Normal-vs-Age(81-100Yrs) |
6.707400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.661200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.779240E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.138200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.968200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.947800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.937000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.514500E-02 |
| Normal-VS-Type2 PRCC |
4.548400E-01 |
| Normal-VS-KIRP CIMP |
1.047970E-02 |
| Normal-VS-Unclassified PRCC |
4.354100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.390000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.808480E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.549400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.135600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.171030E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.092000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.486800E-01 |
| Normal-vs-N1 |
4.282500E-03 |
| Normal-vs-N2 |
1.469630E-01 |
| N0-vs-N1 |
1.232060E-02 |
| N0-vs-N2 |
4.748600E-01 |
| N1-vs-N2 |
5.147800E-01 |
|
|
